SCHEMBL565283

SCHEMBL565283

CC(=O)OC(NCC(C)C(=O)N(Cc1cc(Cl)c2c(c1)OCCCO2)CC(C)C)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.55
MAPK8 P45983 1/20 0.34
TSHR P16473 3/20 0.33
MAPT P10636 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
ALDH1A1 P00352 2/20 0.32
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565782 0.92 PROKR2 (0.57) PROKR2MAPK8TSHRMAPTHDAC3
SCHEMBL564885 0.92 PROKR2 (0.57) PROKR2MAPK8TSHRMAPTHDAC3
SCHEMBL564265 0.91 PROKR2 (0.55) PROKR2MAPK8TSHRMAPTHDAC3
SCHEMBL565288 0.88 PROKR2 (0.59) PROKR2MAPK8MAPTHDAC3HDAC4
Ethane SCHEMBL564959 0.88 PROKR2 (0.59) PROKR2MAPK8MAPTHDAC3HDAC4
SCHEMBL564753 0.88 PROKR2 (0.59) PROKR2MAPK8TSHRHDAC3HDAC4
SCHEMBL565650 0.87 PROKR2 (0.58) PROKR2MAPK8TSHRHDAC3HDAC4
SCHEMBL565033 0.87 PROKR2 (0.58) PROKR2MAPK8TSHRHDAC3HDAC4
SCHEMBL565269 0.87 PROKR2 (0.58) PROKR2MAPK8TSHRHDAC3HDAC4
SCHEMBL564837 0.87 PROKR2 (0.58) PROKR2MAPK8TSHRHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885MAPK8 1270/4885TSHR 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.